NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,632,000 | +2198.8% | 381,600 | +6912.1% | 0.01% | +1200.0% |
| Q3 2018 | $332,000 | -72.6% | 5,442 | -78.0% | 0.00% | 0.0% |
| Q2 2018 | $1,210,000 | -79.7% | 24,782 | -55.8% | 0.00% | -92.9% |
| Q1 2018 | $5,964,000 | -41.4% | 56,122 | -67.1% | 0.01% | +27.3% |
| Q4 2017 | $10,184,000 | +525.9% | 170,530 | +151.6% | 0.01% | +175.0% |
| Q3 2017 | $1,627,000 | +12.6% | 67,781 | -48.4% | 0.00% | +33.3% |
| Q1 2015 | $1,445,000 | -31.6% | 131,287 | -3.8% | 0.00% | -25.0% |
| Q4 2014 | $2,114,000 | +27.7% | 136,405 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,655,000 | -4.3% | 137,147 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $1,729,000 | +5.9% | 134,846 | +0.1% | 0.00% | 0.0% |
| Q1 2014 | $1,632,000 | – | 134,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |